(Q44240132)

English

Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer

scientific article published in December 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

0 references

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Woo-kyoung Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Jong-yeun Park

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Eun Hee Yang

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Hearan Suh

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sung Hoon Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Kihwan Choi

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Chul Woo Yang

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Jong-sang Park

9

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Journal of Controlled Release

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

84

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

115-123

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Cyclosporine: a new immunosuppressive agent for organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900239-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical use of cyclosporin in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900239-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of bile on cyclosporin absorption in liver transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900239-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic drug interactions with cyclosporin (Part I).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900239-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinically significant drug interactions with cyclosporin. An update

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900239-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal toxicity of long-term cyclosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900239-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporine neurotoxicity: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900239-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic utility of whole blood cyclosporine measurements in renal transplantation using triple therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900239-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900239-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Switching between cyclosporin formulations. What are the risks?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900239-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine*

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900239-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Promotion of the selective lymphatic delivery of cyclosporin A by lipid-surfactant mixed micelles.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900239-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A polycaprolactone nanoparticle formulation of cyclosporin-A improves the prediction of area under the curve using a limited sampling strategy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900239-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Modification of release rates of cyclosporin A from polyl(L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900239-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900239-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and characterization of CyA-loaded poly(lactic acid)–poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900239-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900239-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900239-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-3659(02)00239-0

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44240132&oldid=2108852797"